2019論文業績
論文・著書：
- Nanmoku K, Owada Y, Oshiro Y, Kurosawa A, Kubo T, Shinzato T, Shimizu T, Kimura T, Sakuma Y, Ishikawa N, Ohkohchi N, Okamoto H, Yagisawa T. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan. Transpl Infect Dis. 2019 Apr;21(2):e13033.
- Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Effects of denosumab on hypercalcemia and bone mineral density loss in kidney transplant recipients. Clin Nephrol. 2019 Apr 16. doi: 10.5414/CN109723.
- Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports. Transplant Proc. 2019 May 51:1424-1427.
- Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Remission of Epstein-Barr virus-positive post-transplant lymphoproliferative disorder by conversion to everolimus in a kidney transplant recipient. Transpl Infect Dis. 2019 May 18:e13116. doi: 10.1111/tid.13116.
- Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Effect of Rabbit Antithymocyte Globulin on Acute and Chronic Active Antibody-Mediated Rejection After Kidney Transplantation. Transplant Proc. 2019 Oct;51(8):2602-2605.
- Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Association Between Peripheral Blood CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients. Transplant Direct. 2019 Jun 27;5(7):e467. doi: 10.1097/TXD.0000000000000907. eCollection 2019 Jul.
- Nanmoku K, Kawabata N, Kinoshita Y, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Deterioration of presarcopenia and its risk factors following kidney transplantation. Clin Exp Nephrol. 2019 Dec 26. doi: 10.1007/s10157-019-01835-1.
- Shinzato T, Kubo T, Shimizu T, Nanmoku K, Yagisawa T. Sarcoidosis in the renal allograft of a recipient whose primary disease was autosomal dominant polycystic kidney disease. CEN Case Rep. 2019 May;8(2):79-82.
- Shinzato T, Kubo T, Shimizu T, Nanmoku K, Yagisawa T. Fibrosing cholestatic hepatitis in a kidney transplant recipient with hepatitis C virus. CEN Case Rep. 2019 May;8(2):101-105.
- Shimizu T, Kinoshita Y, Kubo T, Shinzato T, Nanmoku K, Yagisawa T: Usefulness of retroperitoneoscopic renal needle biopsy for patients with contraindications for percutaneous renal biopsy. International Urology and Nephrology (2019) 51:2091–2092
- Yagisawa T, Mieno M, Ichimaru N, Morita K, Nakamura M, Hotta K, Kenmochi T, Yuzawa K: Trends of kidney transplantation in Japan in 2018: data from the kidney transplant registry. Renal Replacement Therapy 2019 5: 3
- Fujiwara S, Ikeda T, Morita K, Shinzato T, Ishikawa N, Nakamura N, Yagisawa T, Kanda Y: Multiple myeloma derived from a kidney transplant donor who also developed myeloma sfter kidney donation. Am J Transplant 2019; 19(8): 2374-2377
- 南木浩二：腎不全外科のupdate 腎移植手術―手術手技と注意点．月刊腎臓内科・泌尿器科 9(2) 127‐133 2019年2月
- 阿南 剛、長浜正彦、新保正貴、小松健司、松下一仁、遠藤文康、南木浩二、佐久間康成、八木澤隆、服部一紀、中山昌明：腎臓内科・泌尿器科の集学的アプローチによる生体腎移植導入の提案、日本臨床腎移植学会雑誌 7(2) 185-188, 2019
- 八木澤隆：腎移植の最新の統計と成績、特集、腎移植臨床の進歩、臨床泌尿器科2019；73(10)：690－696
- 八木澤隆： 腎移植術、Urologic Surgery NEXT No. 4、オープンサージェリー、土谷順彦、担当編集、メジカルビュー社、東京、p174 - 186、2019
- 八木澤隆： 第15章 腎移植、血液浄化療法ハンドブック2019、透析療法合同専門委員会編、協同医書出版社、東京p 363-376, 2019